An analysis of the complete genetic code of hundreds of breast tumours could lead to more personalised care for patients.
We explore how we got to where we are today with DNA sequencing and the science behind it.
A gene test may improve the way doctors treating women with early-stage breast cancer identify those who can safely avoid post-surgery chemotherapy.
We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.
Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.
As part of an international collaboration, our researchers have uncovered a link between a rare genetic syndrome and childhood brain tumours.
From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.
We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer.
The sixth of our Grand Challenge topics is posing the question: can we target the cancer ‘super-controller’ MYC?